Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial

BACKGROUND: Fluticasone furoate (FF) is a novel, once-daily inhaled corticosteroid (ICS) that has been shown to improve lung function vs. placebo in asthma patients. This study evaluated the efficacy and safety of FF 50 mcg compared with placebo in asthma patients uncontrolled by non-ICS therapy. ME...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Res
Main Authors: O’Byrne, Paul M, Woodcock, Ashley, Bleecker, Eugene R, Bateman, Eric D, Lötvall, Jan, Forth, Richard, Medley, Hilary, Jacques, Loretta, Busse, William W
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4256920/
https://ncbi.nlm.nih.gov/pubmed/25108545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-014-0088-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados